MIM
ELDN icon

Marco Investment Management’s Eledon Pharmaceuticals ELDN Stock Holding History

Marco Investment Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$93.5K Hold
30,344
– – 0.01% 231
2025
Q4 		$45.8K Hold
30,344
– – ﹤0.01% 227
2025
Q3 		$78.6K Hold
30,344
– – 0.01% 221
2025
Q2 		$82.2K Hold
30,344
– – 0.01% 218
2025
Q1 		$103K Hold
30,344
– – 0.01% 211
2024
Q4 		$125K Hold
30,344
– – 0.01% 220
2024
Q3 		$75.6K Hold
30,344
– – 0.01% 224
2024
Q2 		$80.1K Buy
30,344
+5,535
+22% +$13.2K 0.01% 207
2024
Q1 		$51.1K Buy
+24,809
New +$44.3K ﹤0.01% 207

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Marco Investment Management's ELDN Position: Q1 2026 in Review

Marco Investment Management held its Eledon Pharmaceuticals (ELDN) position steady in Q1 2026 at 30,344 shares worth $93.5K. The position accounts for 0.01% of the portfolio, ranked #231.

Marco Investment Management first reported a position in ELDN in Q1 2024 and has held it in 9 quarters since. The position peaked at $125K in Q4 2024. 121 funds tracked by Wall St. Rank hold ELDN as of Q1 2026.

  • Marco Investment Management held 30,344 shares of Eledon Pharmaceuticals worth $93.5K as of Q1 2026.
  • Marco Investment Management left its Eledon Pharmaceuticals share count unchanged in Q1 2026.
  • Eledon Pharmaceuticals made up 0.01% of Marco Investment Management's portfolio in Q1 2026, its #231 holding.
  • Marco Investment Management first reported a position in Eledon Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • Marco Investment Management's Eledon Pharmaceuticals position peaked at $125K in Q4 2024.
  • 121 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2026.

Based on Marco Investment Management's 13F filing for Q1 2026, filed 8 May 2026.